The mammalian gastrointestinal tract is covered by a layer of mucus that can harbour a range of bacterial species specifically adapted to colonize this ecological niche. Examination of 110 bacterial isolates cultivated from the gastrointestinal tract of 23 mice revealed the presence of a subgroup of 30 isolates that did not correspond genetically with genera commonly associated with this site, i.e. members of the e-Proteobacteria such as Helicobacter and Campylobacter species. Instead this group of isolates was found to lie within the phylum Deferribacteres, a completely distinct lineage in the domain Bacteria. There was a high level of consensus in results obtained from the phenotypic and genotypic characterization of a number of the isolates, which showed they were distinct from other members of the Deferribacteres. As such, they are proposed to constitute a new genus and species, Mucispirillum schaedleri gen. nov., sp. nov. These organisms are anaerobic, Gram-negative, spiral-shaped rods with bipolar flagella. The type strain is HRI I17T (=ATCC BAA-1009 T =ACM 5223 T ).
INTRODUCTIONThe layer of mucus that lines the mammalian gastrointestinal tract (GT) represents a complex ecological niche (Lee, 1980). We have previously hypothesized that bacteria capable of colonizing this site possess specialized characteristics, such as spiral morphology and motility, which give them a selective advantage over other bacterial types in viscous environments and that spiral bacteria have coevolved with their mammalian hosts (Lee, 1985). For example, the mucus lining of the GT of rodents harbours large and often diverse populations of spiral bacteria, many of which have been found to be members of the genera Helicobacter and Campylobacter (Davis et al., 1972;Erlandsen & Chase, 1972;Gordon & Dubos, 1970;Lee et al., 1968;Phillips et al., 1978;Savage & Blumershine, 1974).Recently, a major emphasis of research into GT disease has focused on the role such bacteria, specifically the spiralshaped Helicobacter species, play in the disease processes. In addition to Helicobacter pylori being shown to be a causative agent in gastric disease, there is now accumulating evidence that many other Helicobacter species may be implicated in other gastrointestinal and hepatobiliary diseases, including enteritis, inflammatory bowel disease (IBD), typhlitis, hepatitis and hepatic neoplasia (Fox, 2002;O'Rourke et al., 2001;Schauer, 2001). GT research relies on the mouse as an important animal model for studies on pathogenicity and underpins much of the current research on anti-Helicobacter vaccine development. However, our knowledge of the identity of the many spiral-shaped bacteria that are capable of colonizing the mammalian GT is limited and should not be restricted to Helicobacter species. Therefore, it has become a priority to determine the identity of spiral bacteria naturally occurring in laboratory rodents. Although many Helicobacter species have been identified in laboratory mice and rats (Fox et al., 1994(Fox et al., , 1995Lee et al., 1992...